Glycotope Winner at STEP Award 2010
Glycotope GmbH has been awarded with the 2010 STEP-Award for financing. Glycotope was selected for its strategically aligned and long-term funding concept.
CFO Dr. Franzpeter Bracht stated: “In addition to our outstanding technology, from the beginning we have put great emphasis on a balanced mix of revenues and investments."
"The extraordinary financial commitment by Drs. Thomas and Andreas Strüngmann has been of tremendous help though and secured the long term growth of our company, based on our outstanding technology the basis for our largely improved biopharmaceuticals developed by our CEO, CSO and founder Dr. Steffen Goletz” states Dr. Hans Baumeister, COO. Even ahead of entering pipeline- and technology-related licensing agreements, Glycotope has thus been able to cover a large proportion of its expenditures via its contract research, manufacturing and diagnostics business.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.